0 Recommendations

A ray of hope for Malignant Mesothelioma Vs Diagnostc Biomarker

By Binaya Kafle | 15 Sep, 2018

Management of Inoperable intrathoracic neoplasms has undergone considerable amount of debate over past years. Recently a team of doctors from Japan successfully treated the recurrence of mesothelioma without post operative complications. The patient is said to have no recurrence even upto 2 years from treatment.

However, implementation of post treatment biomarkers have been seen to be lacking as in most of the previous studies. Are there any bio-markers effective to predict outcomes following RFA? Please find the research here https://updatemedicine.com/mesothelioma-recurrence-successfully-treated-with-...

Attached resource:

This Community is Archived.

This community is no longer active as of December 2018. Thanks to those who posted here and made this information available to others visiting the site.